CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Streck’s A1c-Cellular HbA1c control with intact red blood cells is now assayed for Roche Diagnostics’ Cobas c311.
A1c-Cellular tests the entire HbA1c procedure, including the lysing of the red blood cell. This step ensures that the entire system—instrument and reagents—is working properly and providing accurate patient results. The control is easy to use; it does not require reconstitution, which reduces the potential for human error.
A1c-Cellular is for immunoassay and ionic exchange high-performance liquid chromatography methods. It is also assayed for Abbott Architect c systems; Arkray Menarini Adams A1c HA-8160; Beckman Coulter UniCel DxC 600/800 Synchron; Bio-Rad D10/Variant II/Variant II Turbo; Ortho-Clinical Diagnostics Vitros 5, 1 FS/Vitros 5600; Roche Cobas Integra/Cobas 6000; Siemens Healthcare Diagnostics Dimension series; and the Tosoh A1c 2.2 Plus/G7/G8.
Available in 2.0-mL plastic screw-top cap-pierceable vials, the control has a closed-vial stability of six months and an open-vial stability of 30 days.
Streck, 800-843-0912